In silico clinical trials: concepts and early adoptions

Innovations in information and communication technology infuse all branches of science, including life sciences. Nevertheless, healthcare is historically slow in adopting technological innovation, compared with other industrial sectors. In recent years, new approaches in modelling and simulation have started to provide important insights in biomedicine, opening the way for their potential use in the reduction, refinement and partial substitution of both animal and human experimentation. In light of this evidence, the European Parliament and the United States Congress made similar recommendations to their respective regulators to allow wider use of modelling and simulation within the regulatory process. In the context of in silico medicine, the term 'in silico clinical trials' refers to the development of patient-specific models to form virtual cohorts for testing the safety and/or efficacy of new drugs and of new medical devices. Moreover, it could be envisaged that a virtual set of patients could complement a clinical trial (reducing the number of enrolled patients and improving statistical significance), and/or advise clinical decisions. This article will review the current state of in silico clinical trials and outline directions for a full-scale adoption of patient-specific modelling and simulation in the regulatory evaluation of biomedical products. In particular, we will focus on the development of vaccine therapies, which represents, in our opinion, an ideal target for this innovative approach.

[1]  Alessandro Lombardo,et al.  A computational model to predict the immune system activation by citrus-derived vaccine adjuvants , 2016, Bioinform..

[2]  A. S. Popel,et al.  The Microcirculation Physiome Project , 1998, Annals of Biomedical Engineering.

[3]  K. Rejniak,et al.  Current trends in mathematical modeling of tumor–microenvironment interactions: a survey of tools and applications , 2010, Experimental biology and medicine.

[4]  Giovanni Vozzi,et al.  In Silico Models for Dynamic Connected Cell Cultures Mimicking Hepatocyte-Endothelial Cell-Adipocyte Interaction Circle , 2014, PloS one.

[5]  R. Schreiber,et al.  IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity , 2001, Nature.

[6]  Alessandro Sette,et al.  Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method , 2005, BMC Bioinformatics.

[7]  Chih-Lin Chi,et al.  Personalized Anticoagulation: Optimizing Warfarin Management Using Genetics and Simulated Clinical Trials , 2017, Circulation. Cardiovascular genetics.

[8]  J B Bassingthwaighte.  Design and strategy for the Cardionome Project. , 1997, Advances in experimental medicine and biology.

[9]  M. De Curtis,et al.  Update in Pathogenesis and Prospective in Treatment of Necrotizing Enterocolitis , 2014, BioMed research international.

[10]  E. Davidov,et al.  Advancing drug discovery through systems biology. , 2003, Drug discovery today.

[11]  Dawn Walker,et al.  A Complex Automata approach for in-stent restenosis: Two-dimensional multiscale modelling and simulations , 2011, J. Comput. Sci..

[12]  Gary An,et al.  In silico augmentation of the drug development pipeline: examples from the study of acute inflammation , 2011, Drug development research.

[13]  Giulia Russo,et al.  Computational modeling of the expansion of human cord blood CD133+ hematopoietic stem/progenitor cells with different cytokine combinations , 2015, Bioinform..

[14]  Saeed Alqahtani,et al.  In silico ADME-Tox modeling: progress and prospects , 2017, Expert opinion on drug metabolism & toxicology.

[15]  Ellis L Reinherz,et al.  Definition of MHC Supertypes Through Clustering of MHC Peptide Binding Repertoires , 2004, ICARIS.

[16]  Y. Vodovotz,et al.  Trauma in silico: Individual-specific mathematical models and virtual clinical populations , 2015, Science Translational Medicine.

[17]  Greg Lemon,et al.  The Use of Mathematical Modelling for Improving the Tissue Engineering of Organs and Stem Cell Therapy. , 2016, Current stem cell research & therapy.

[18]  Alexander J Makowski,et al.  Predicting mouse vertebra strength with micro-computed tomography-derived finite element analysis. , 2015, BoneKEy reports.

[19]  T. Ideker,et al.  A new approach to decoding life: systems biology. , 2001, Annual review of genomics and human genetics.

[20]  Salvatore Cavalieri,et al.  A methodological approach for using high-level Petri Nets to model the immune system response , 2016, BMC Bioinformatics.

[21]  Vladimir Brusic,et al.  Combining cellular automata and Lattice Boltzmann method to model multiscale avascular tumor growth coupled with nutrient diffusion and immune competition. , 2012, Journal of immunological methods.

[22]  R S Srinivasan,et al.  Application of Physiologically Based Pharmacokinetic Models for Assessing Drug Disposition in Space , 1994, Journal of clinical pharmacology.

[23]  Paul B Watkins,et al.  In silico modeling to optimize interpretation of liver safety biomarkers in clinical trials , 2018, Experimental biology and medicine.

[24]  Russ B. Altman,et al.  Research Paper: Using Petri Net Tools to Study Properties and Dynamics of Biological Systems , 2004, J. Am. Medical Informatics Assoc..

[25]  P. Hunter,et al.  The Virtual Physiological Human: Ten Years After. , 2016, Annual review of biomedical engineering.

[26]  C A Nichol,et al.  Pharmacokinetics. Selectivity of action related to physicochemical properties and kinetic patterns of anticancer drugs , 1977, Cancer.

[27]  Adam Himes,et al.  Incorporation of stochastic engineering models as prior information in Bayesian medical device trials , 2017, Journal of biopharmaceutical statistics.

[28]  Oliver J. Britton,et al.  Human In Silico Drug Trials Demonstrate Higher Accuracy than Animal Models in Predicting Clinical Pro-Arrhythmic Cardiotoxicity , 2017, Front. Physiol..

[29]  Gordon Clapworthy,et al.  The Virtual Physiological Human - a European initiative for in silico human modelling -. , 2008, The journal of physiological sciences : JPS.

[30]  P J Hunter,et al.  The IUPS Physiome Project. International Union of Physiological Sciences. , 2002, Novartis Foundation symposium.

[31]  Kevin Burrage,et al.  Bridging experiments, models and simulations: an integrative approach to validation in computational cardiac electrophysiology. , 2012, American journal of physiology. Heart and circulatory physiology.

[32]  R J Roman,et al.  A Genomic-Systems Biology Map for Cardiovascular Function , 2001, Science.

[33]  Marco Viceconti,et al.  In silico clinical trials: how computer simulation will transform the biomedical industry , 2016 .

[34]  John F. Young,et al.  A physiologically based pharmacokinetic computer model for human pregnancy. , 1994, Teratology.

[35]  M. Danhof,et al.  Generating Virtual Patients by Multivariate and Discrete Re-Sampling Techniques , 2015, Pharmaceutical Research.

[36]  Sylvain V Costes,et al.  Phenotypic transition maps of 3D breast acini obtained by imaging-guided agent-based modeling. , 2011, Integrative biology : quantitative biosciences from nano to macro.

[37]  R. G. Janes,et al.  The analysis of glucose measurements by computer simulation. , 1965, The Journal of physiology.

[38]  Marco Beccuti,et al.  Multi-level model for the investigation of oncoantigen-driven vaccination effect , 2013, BMC Bioinformatics.

[39]  Francesco Pappalardo,et al.  Computational modelling approaches to vaccinology. , 2015, Pharmacological research.

[40]  Lewis B. Sheiner,et al.  Some suggestions for measuring predictive performance , 1981, Journal of Pharmacokinetics and Biopharmaceutics.

[41]  D C Swinney,et al.  Phenotypic vs. Target‐Based Drug Discovery for First‐in‐Class Medicines , 2013, Clinical pharmacology and therapeutics.

[42]  M. G. Cogan,et al.  Regulation of proximal bicarbonate reabsorption. , 1984, The American journal of physiology.

[43]  Marco Viceconti,et al.  Longitudinal effects of Parathyroid Hormone treatment on morphological, densitometric and mechanical properties of mouse tibia. , 2017, Journal of the mechanical behavior of biomedical materials.

[44]  R. Rappuoli,et al.  Reverse vaccinology, a genome-based approach to vaccine development. , 2001 .

[45]  A S BURGEN,et al.  Application of analogue computer to measurement of intestinal absorption rates with tracers. , 1961, Journal of applied physiology.

[46]  Michael Campbell,et al.  Fracture prediction of cardiac lead medical devices using Bayesian networks , 2013, Reliab. Eng. Syst. Saf..

[47]  Stefan Schuster,et al.  Topological analysis of metabolic networks based on Petri net theory , 2003, Silico Biol..

[48]  Suresh Kumar,et al.  In silico repurposing of antipsychotic drugs for Alzheimer’s disease , 2017, BMC Neuroscience.

[49]  Jeffrey Shuren,et al.  An FDA Viewpoint on Unique Considerations for Medical-Device Clinical Trials. , 2017, The New England journal of medicine.

[50]  M. Viceconti,et al.  Patient-specific finite element estimated femur strength as a predictor of the risk of hip fracture: the effect of methodological determinants , 2016, Osteoporosis International.

[51]  Parashkev Nachev,et al.  High-dimensional therapeutic inference in the focally damaged human brain , 2017, Brain : a journal of neurology.

[52]  Bhartendu Nath Mishra,et al.  Major histocompatibility complex linked databases and prediction tools for designing vaccines. , 2016, Human immunology.

[53]  Urmila Kulkarni-Kale,et al.  T-cell epitope prediction methods: an overview. , 2014, Methods in molecular biology.

[54]  J. Gunn,et al.  Computational fluid dynamics modelling in cardiovascular medicine , 2015, Heart.

[55]  L. Geris,et al.  In silico clinical trials for pediatric orphan diseases , 2018, Scientific Reports.

[56]  Urmila Diwekar,et al.  Optimal control for predicting customized drug dosage for superovulation stage of in vitro fertilization. , 2014, Journal of theoretical biology.

[57]  A. Cavalli,et al.  Role of Molecular Dynamics and Related Methods in Drug Discovery. , 2016, Journal of medicinal chemistry.

[58]  C. Anthony Hunt,et al.  Simulating Properties of In Vitro Epithelial Cell Morphogenesis , 2006, PLoS Comput. Biol..

[59]  E. Niclas Jonsson,et al.  PsN-Toolkit - A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM , 2005, Comput. Methods Programs Biomed..

[60]  Xiaomei Zhuang,et al.  PBPK modeling and simulation in drug research and development , 2016, Acta pharmaceutica Sinica. B.

[61]  Marco Viceconti,et al.  In silico assessment of biomedical products: The conundrum of rare but not so rare events in two case studies , 2017, Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine.

[62]  Peter P. Lee,et al.  Modeling Protective Anti-Tumor Immunity via Preventative Cancer Vaccines Using a Hybrid Agent-based and Delay Differential Equation Approach , 2012, PLoS Comput. Biol..

[63]  H. Kitano.  Systems Biology: A Brief Overview , 2002, Science.

[64]  Ferdinando Chiacchio,et al.  Optimal vaccination schedule search using genetic algorithm over MPI technology , 2012, BMC Medical Informatics and Decision Making.

[65]  Pedro A Reche,et al.  Prediction of MHC-peptide binding: a systematic and comprehensive overview. , 2009, Current pharmaceutical design.

[66]  Filippo Castiglione,et al.  Vaccine protocols optimization: in silico experiences. , 2010, Biotechnology advances.

[67]  Monika Heiner,et al.  Application of Petri net based analysis techniques to signal transduction pathways , 2006, BMC Bioinformatics.

[68]  Marco Viceconti,et al.  Pre-clinical validation of joint prostheses: a systematic approach. , 2009, Journal of the mechanical behavior of biomedical materials.

[69]  Mehmet Burcin Unlu,et al.  Quantifying the effects of antiangiogenic and chemotherapy drug combinations on drug delivery and treatment efficacy , 2017, PLoS Comput. Biol..

[70]  Francesco Pappalardo,et al.  Continuous Petri Nets and microRNA Analysis in Melanoma , 2018, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[71]  J W Fisher,et al.  Computer simulation of the lactational transfer of tetrachloroethylene in rats using a physiologically based model. , 1994, Toxicology and applied pharmacology.

[72]  Mark Taylor,et al.  Four decades of finite element analysis of orthopaedic devices: where are we now and what are the opportunities? , 2015, Journal of biomechanics.

[73]  Filippo Castiglione,et al.  Modeling Biology Spanning Different Scales: An Open Challenge , 2014, BioMed research international.